Kiran Mazumdar-Shaw set out on a journey in 1978 to transform the global biopharma industry. She started with just ₹10,000 equipped with a vision for affordable healthcare. She founded Biocon in a small garage in Bengaluru and it was a humble beginning. The company is today a ₹30,000 crore biopharma giant.
The story of Kiran is truly inspiring in a male-dominated industry. She faced doubts and challenges from the very start, but these obstacles didn’t stop her. Her vision and determination helped Biocon to become a leader in the biopharmaceutical sector.
Biocon has made essential medicines more accessible and is well-known for providing cost-effective alternatives to expensive biologics.
Kiran has always emphasized the importance of research and development. Investment of the company in developing novel molecules to fight critical diseases has earned Biocon a reputation for producing cutting-edge therapies. The insulin analog Glargine and anti-cancer treatments are just a few of its examples.
The global collaborations of Biocon with companies like Mylan (now Viatris) and Sandoz have strengthened its presence worldwide. The partnerships have helped the company to expand reach more overseas markets.
Kiran today is a role model for aspiring entrepreneurs and especially for women. She has proved that right vision can break barriers. She also voices for gender equity and her philanthropic work through the Mazumdar-Shaw Medical Foundation is addressing critical health issues in India.
The journey of Kiran from a garage startup to the head of a ₹30,000 crore biopharma giant is outstanding.
